Toru Tateno

949 total citations
32 papers, 745 citations indexed

About

Toru Tateno is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Epidemiology. According to data from OpenAlex, Toru Tateno has authored 32 papers receiving a total of 745 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Endocrinology, Diabetes and Metabolism, 12 papers in Molecular Biology and 9 papers in Epidemiology. Recurrent topics in Toru Tateno's work include Pituitary Gland Disorders and Treatments (22 papers), Neuroendocrine Tumor Research Advances (8 papers) and Glioma Diagnosis and Treatment (6 papers). Toru Tateno is often cited by papers focused on Pituitary Gland Disorders and Treatments (22 papers), Neuroendocrine Tumor Research Advances (8 papers) and Glioma Diagnosis and Treatment (6 papers). Toru Tateno collaborates with scholars based in Japan, Canada and Singapore. Toru Tateno's co-authors include Yukio Hirata, Takanobu Yoshimoto, Masayoshi Shichiri, L. Sylvia, Shereen Ezzat, Yuki Hirono, Masaru Doi, Hajime Izumiyama, Toru Sugiyama and Shozo Yamada and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Endocrinology and PLoS Genetics.

In The Last Decade

Toru Tateno

29 papers receiving 733 citations

Peers

Countries citing papers authored by Toru Tateno

Since Specialization

Citations

This map shows the geographic impact of Toru Tateno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toru Tateno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toru Tateno more than expected).

Fields of papers citing papers by Toru Tateno

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toru Tateno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toru Tateno. The network helps show where Toru Tateno may publish in the future.

Co-authorship network of co-authors of Toru Tateno

This figure shows the co-authorship network connecting the top 25 collaborators of Toru Tateno. A scholar is included among the top collaborators of Toru Tateno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toru Tateno. Toru Tateno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Autophagy inhibition suppresses hormone production and cell growth in pituitary tumor cells: A potential approach to pituitary tumors 2024 ·Molecular and Cellular Endocrinology ·Motoyasu Satou, Jason Wang, (unknown), (unknown), Shigeki Aoki, Hiroyuki Sugimoto, Constance L. Chik, Toru Tateno	1
2	Pituitary Neuroendocrine Tumors in Multiple Endocrine Neoplasia 2024 ·Endocrinology and Metabolism ·Sang Ouk Chin, Constance L. Chik, Toru Tateno	0
3	Touch imprint cytology is useful for the intraoperative pathological diagnosis of PitNETs’ surgical margins 2023 ·Brain Tumor Pathology ·Noriaki Tanabe, Naoko Inoshita, Atsushi Ishida, Masataka Kato, (unknown), (unknown), Hidetaka Suga, Toru Tateno, Kenichi Ohashi, Shozo Yamada	3
4	Paraganglioma with High Levels of Dopamine, Dopa Decarboxylase Suppression, Dopamine β-hydroxylase Upregulation and Intra-tumoral Melanin Accumulation: A Case Report with a Literature Review 2022 ·Internal Medicine ·Masahiro Nezu, Yosuke Hirotsu, Kenji Amemiya, Toru Tateno, Soichi Takizawa, Masaharu Inoue, Hitoshi Mochizuki, (unknown), Constance L. Chik, Toshio Oyama, Masao Omata	2
5	Multimodal Non-Surgical Treatments of Aggressive Pituitary Tumors 2021 ·Frontiers in Endocrinology ·(unknown), (unknown), Justin Z. Wang, (unknown), Yasuhiko Kawakami, Toru Tateno, Takako Araki	19
6	L-type amino acid transporter 1, LAT1, in growth hormone-producing pituitary tumor cells 2020 ·Molecular and Cellular Endocrinology ·Motoyasu Satou, Jason Wang, (unknown), (unknown), Tokiko Suzuki, Keitaro Hayashi, Shawn M. Lamothe, Yubin Hao, Harley T. Kurata, Hiroyuki Sugimoto, Constance L. Chik, Toru Tateno	15
7	Effects of CAPTEM (Capecitabine and Temozolomide) on a Corticotroph Carcinoma and an Aggressive Corticotroph Tumor 2020 ·Endocrine Pathology ·(unknown), Motoyasu Satou, Naoko Inoshita, Frank K.H. van Landeghem, (unknown), Vivek Mehta, Toru Tateno, Constance L. Chik	17
8	NG2 targets tumorigenic Rb inactivation in Pit1-lineage pituitary cells 2016 ·Endocrine Related Cancer ·Toru Tateno, (unknown), Shereen Ezzat, L. Sylvia	8
9	FGFR4 Polymorphic Variants Modulate Phenotypic Features of Cushing Disease 2014 ·Molecular Endocrinology ·(unknown), Toru Tateno, (unknown), Lei Zheng, Katsuhiko Yoshimoto, Shozo Yamada, L. Sylvia, Shereen Ezzat	14
10	The PI3K/AKT/mTOR pathway in the pathophysiology and treatment of pituitary adenomas 2014 ·Endocrine Related Cancer ·Eric Monsalves, Kyle Juraschka, Toru Tateno, Sameer Agnihotri, L. Sylvia, Shereen Ezzat, Gelareh Zadeh	62
11	The FGFR4-G388R Polymorphism Promotes Mitochondrial STAT3 Serine Phosphorylation to Facilitate Pituitary Growth Hormone Cell Tumorigenesis 2011 ·PLoS Genetics ·Toru Tateno, L. Sylvia, Lei Zheng, Thomas Mayr, Axel Ullrich, Shereen Ezzat	52
12	Chromatin remodeling and histone modifications in pituitary tumors 2010 ·Molecular and Cellular Endocrinology ·Toru Tateno, Xuegong Zhu, L. Sylvia, Shereen Ezzat	15
13	Processing of high-molecular-weight form adrenocorticotropin in human adrenocorticotropin-secreting tumor cell line (DMS-79) after transfection of prohormone convertase 1/3 gene 2009 ·Journal of Endocrinological Investigation ·Toru Tateno, Masako Kato, Yoshiko Tani, Takanobu Yoshimoto, Yutaka Oki, Yoko Hirata	4
14	Differential gene expression in ACTH -secreting and non-functioning pituitary tumors 2007 ·European Journal of Endocrinology ·Toru Tateno, Hajime Izumiyama, Masaru Doi, Takanobu Yoshimoto, Masayoshi Shichiri, Naoko Inoshita, Kenichi Oyama, Shozo Yamada, Yukio Hirata	75
15	Defective Expression of Prohormone Convertase 1/3 in Silent Corticotroph Adenoma 2007 ·Endocrine Journal ·Toru Tateno, Hajime Izumiyama, Masaru Doi, Takumi Akashi, Kikuo Ohno, Yukio Hirata	33
16	Angiotensin II induces monocyte chemoattractant protein-1 expression via a nuclear factor-κB-dependent pathway in rat preadipocytes 2006 ·American Journal of Physiology-Endocrinology and Metabolism ·Kyoichiro Tsuchiya, Takanobu Yoshimoto, Yuki Hirono, Toru Tateno, Toru Sugiyama, Yukio Hirata	52
17	Role of C‐terminus of Kir7.1 potassium channel in cell‐surface expression 2006 ·Cell Biology International ·Toru Tateno, Nobuhiro Nakamura, Yukio Hirata, Shigehisa Hirose	14
18	Presence of immunoreactive salusin-α in human serum and urine 2006 ·Peptides ·Kengo Sato, Takatoshi Koyama, Toru Tateno, Yukio Hirata, Masayoshi Shichiri	46
19	Aldosterone increases osteopontin gene expression in rat endothelial cells 2005 ·Biochemical and Biophysical Research Communications ·Toru Sugiyama, Takanobu Yoshimoto, Yuki Hirono, Noriko Suzuki, Maya Sakurada, Kyoichiro Tsuchiya, Isao Minami, (unknown), (unknown), Toru Tateno, Ryuji Sato, Yukio Hirata	29
20	Olfactory Neuroblastoma Causing Ectopic ACTH Syndrome 2005 ·Endocrine Journal ·Kazuo Kanno, (unknown), Toru Tateno, Yuki Hirono, Kazuhiro Taki, R. Yoshiyuki Osamura, Yukio Hirata	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact